AnaCardio raised €14M in a Series A round in Sep 2022. The company is based in Stockholm, Sweden. Investors in the round: 3B Health Ventures, Flerie Invest, Fredrik and Ann-Helene Ljungström and 2 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
